RSS

Nosopharm

A study has been published looking at the mechanism of action of odilorhabdins — a new class of antibiotics — to combat antibiotic resistance, disclosed Nosopharm and the University of Illinois at Chicago (UIC) more

News

A company dedicated to the research and development of new anti-infective drugs, Nosopharm, has received funding from Bpifrance worth €1 million in the form of an interest-free loan. more

News

Nosopharm, a biotechnology company specialised in the research and development of new antimicrobial molecules, has announced a financing round of €2.4 million. more

News

Nosopharm is to join the European Gram-negative Antibacterial Engine (ENABLE) a project working to advance the development of potential antibiotics against multidrug resistant Gram-negative infections more

News